Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks

| 16 May 2024 4:26 PM IST

New Delhi: Several studies on Covaxin have demonstrated an excellent safety track record, said Bharat Biotech on Thursday, after a study raised concerns of stroke and Guillain-Barre syndrome (rare autoimmune disorder that affects the nerves) a year after taking the Covid-19 vaccine. The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.

Tags: Bharat Biotech

Categories: National

Vidya

Vidya is a talented author and expert in visual journalism, specializing in the creation of impactful infographics. At Newsographics, she transforms complex data into visually engaging news articles that capture audience attention. With a strong background in design and journalism, Vidya advocates for the use of infographics to enhance understanding and accessibility of information, making her a significant voice in modern media practices.